Yang-ling Li
No. 261 Huansha Road
Hangzhou, 310006, China
Hangzhou, 310006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Targeted Therapy-Induced Interstitial Lung Disease in NSCLC: Mechanisms, Clinical Signatures, and a Precision Medicine Roadmap.
Journal: Drug design, development and therapy
Published: February 01, 2026
SLC13 sodium-carboxylate transporters: function, regulation and pathophysiological implications in human disease.
Journal: Biochemical pharmacology
Published: November 03, 2025
Cardiotoxicity of Targeted Therapies in Hematologic Malignancies: From Molecular Mechanisms to Clinical Management.
Journal: Current treatment options in oncology
Published: October 26, 2025
Exosomal circPOLK promotes metastasis of NSCLC cells via regulating mir-1204/SOX8 axis.
Journal: Cancer cell international
Published: September 04, 2025
HTR1D regulates the PI3K/Akt signaling pathway to impact glioblastoma development and resistance to temozolomide.
Journal: Chemico-biological interactions
Published: June 24, 2025
Effect and mechanism of Chinese medicine on inhibiting the senescence of mesenchymal stem cells.
Journal: Chinese journal of natural medicines
Published: March 08, 2025
The function and mechanism of LAPTM5 in diseases.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 05, 2024
POLR2J expression promotes glioblastoma malignancy by regulating oxidative stress and the STAT3 signaling pathway.
Journal: American journal of cancer research
Published: October 24, 2023
Triacanthine enhances the sensitivity of colorectal cancer cells to 5-fluorouracil by regulating RRM2.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: July 15, 2023
DSCC1 interacts with HSP90AB1 and promotes the progression of lung adenocarcinoma via regulating ER stress.
Journal: Cancer cell international
Published: July 09, 2023
Recent research progress of circular RNAs in hepatocellular carcinoma.
Journal: Frontiers in oncology
Published: March 23, 2023
DYRK1A reinforces epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma via cooperatively activating STAT3 and SMAD.
Journal: Journal of biomedical science
Published: February 01, 2022
Last Updated: 09/26/2026